Metformin’s Role in Hyperlactatemia and Lactic Acidosis in ICU Patients: A Systematic Review
Pharmacology · 2023 · 108 (3) · 213-223
DOI: 10.1159/000528252 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pharmacology, online erschienen am 18.01.2023. Verfasst von Livia Mueller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Hyperlactatemia, Acidosis, Lactic, Metformin. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Introduction
Metformin-treated patients may experience severe hyperlactatemia or lactic acidosis (LA). LA often requires intensive-care-unit (ICU) treatment, and mortality rates are high. Here, we investigate the impact of renal dysfunction and renal replacement therapy (RRT) on the outcomes of critically ill patients with metformin-associated LA (MALA). Furthermore, we assessed associations between mortality and metformin dose, metformin plasma/serum concentrations, lactate level, and arterial pH. Finally, we investigated whether the recommended classification in MALA, metformin-unrelated LA, metformin-induced LA, and LA in metformin therapy appears useful in this regard.
Methods
We performed a retrospective analysis based on a systematic PubMed search for publications on hyperlactatemia/LA in metformin-treated ICU patients from January 1995 to February 2020. Case-level data including demographics and clinical conditions were extracted, and logistic regression analyses were performed.
Results
A total of 92 ICU patients were reported. Two of these patients had no comorbidities interfering with lactate metabolism. In the overall group, arterial pH, lactate levels, and metformin plasma/serum concentrations were similar in survivors versus non-survivors. Ingested daily metformin doses and plasma/serum creatinine levels were significantly higher in survivors versus non-survivors (p = 0.007 vs. p = 0.024, respectively). Higher plasma/serum creatinine levels, higher lactate levels, and lower arterial pH were all associated with patients receiving RRT (all p < 0.05). Overall mortality was 22% (20 out of 92 patients) and did not differ between the RRT and non-RRT groups.
Conclusion
Mortality is high in ICU patients with metformin-associated hyperlactatemia/LA. Unexpectedly, higher ingested metformin dose and plasma/serum creatinine were associated with a better outcome. Survival was similar in patients with or without need for RRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Zitieren
APA
Mueller, L., Moser, M., Prazak, J., Fuster, D. G., Schefold, J. C., & Zuercher, P. (2023). Metformin’s Role in Hyperlactatemia and Lactic Acidosis in ICU Patients: A Systematic Review. Pharmacology, 108(3), 213-223. https://doi.org/10.1159/000528252
Vancouver
Mueller L, Moser M, Prazak J, Fuster DG, Schefold JC, Zuercher P. Metformin’s Role in Hyperlactatemia and Lactic Acidosis in ICU Patients: A Systematic Review. Pharmacology. 2023;108(3):213-223. doi:10.1159/000528252
BibTeX
@article{Mueller2023,
author = {Mueller, Livia and Moser, Michel and Prazak, Josef and Fuster, Daniel G and Schefold, Joerg C and Zuercher, Patrick},
title = {Metformin’s Role in Hyperlactatemia and Lactic Acidosis in ICU Patients: A Systematic Review},
journal = {Pharmacology},
year = {2023},
volume = {108},
number = {3},
pages = {213--223},
doi = {10.1159/000528252}
}
EUVIMED